Net income
−$4.8M
+6.1% vs same quarter last year
EPS, diluted
−$0.25
+79.8% vs same quarter last year
Operating cash flow
−$3.7M
+4.6% vs same quarter last year
Operating income
−$4.8M
+6.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$19.4M |
| FY24 | −$30.4M |
| FY23 | −$30M |
| FY22 | −$28.5M |
| FY21 | −$14.7M |
| FY20 | −$8.6M |
| FY19 | - |
News
No stories filed under IN8BIO yet - coverage appears here as the news feed clusters it.